Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TEBENTAFUSP
- Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis
- Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
- Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
- CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer
- A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
- Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
- Tebentafusp-tebn With LDT in Metastatic UM
- Neoadjuvant Tebentafusp for Uveal Melanoma
- Adjuvant Tebentafusp in High Risk Ocular Melanoma
- Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
- Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas
- Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
- Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)
- A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
Clinical trials list
click for details